NeuroFlow, a digital health company founded in 2017, is making waves in the health care industry with its mission to integrate behavioral health in all care settings. Concord Health Partners recently invested in the company during its Venture Round on 06 September 2023. NeuroFlow's slogan "Promoting behavioral health access and engagement in all care settings" encapsulates its core focus. The company offers a technology infrastructure that facilitates the delivery of effective and scalable integrated programs, ultimately improving access to behavioral healthcare while reducing costs. Their suite of services and HIPAA-compliant, cloud-based tools simplifies remote patient monitoring, improves risk stratification, and facilitates collaborative care. NeuroFlow's innovative approach harnesses the power of workflow automation, patient engagement solutions, and applied AI to bridge the gap between physical and mental health. This ultimately leads to improved outcomes and reduced costs of care. For leading healthcare organizations seeking to enhance their behavioral health offerings, NeuroFlow's next-generation software presents a compelling solution. For more information, visit www.neuroflow.com.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | Unknown | 1 | 06 Sep 2023 | |
Series C | $25.00M | 3 | 12 Oct 2022 | |
Grant | $750.00K | 1 | 19 Sep 2022 | |
Series B | $20.00M | 4 | Magellan Health Services | 12 Jan 2021 |
Grant | $749.37K | 1 | 10 Apr 2020 |
No recent news or press coverage available for NeuroFlow.